Saad AM, Kassis N, Isogai T, et al. - Researchers used the Nationwide Readmissions Database to analyze volume and performance trends of aortic valve replacement (AVR) in the USA during 2012-2017. There were 624,303 patients (median age 72 years) who underwent AVR, including 387,011 (62%) males. Among these cases, 170,521 (27%) had transcatheter aortic valve implantation (TAVI) and 453,782 (73%) had surgical aortic valve replacement (SAVR) with 299,398 isolated and 154,384 complex aortic valve surgery. From 2012-2017, a rise in the annual number of TAVI, from 8,295 to 55,168, was evident while SAVR volume continued to be remarkably stable. Significant improvements in mortality, stroke, duration of hospitalization, and 30-day readmission were conferred by AVR. In this large contemporary study, the considerable growth of AVR in the US was documented. It remains unequivocal that the management of aortic stenosis is improving overall with decreased death post-AVR, this demonstrates that various process improvements are effective including newer valves, enhanced patient selection, and the interdisciplinary Heart Team approach.